Modality.AI, Inc. is a venture-backed deep health tech startup based in San Francisco, Canada, and Europe. Modality assesses CNS conditions using speech, language, and visual analytics of conversations elicited by our virtual guide Tina. Our customers use Modality’s FDA-listed platform as objective endpoint in clinical trials (observational through Phase 3) and include big pharma (e.g. J&J), biotech (e.g. Verge Genomics), the federal government (e.g. VA), and world-leading academic research institutions (e.g. MGH).